Citation tools

"Correction to “1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Monofumarate (TAK-438), a Novel and Potent Potassium-Competitive Acid Blocker for the Treatment of Acid-Related Diseases.”." Journal of Pharmacology and Experimental Therapeutics 358.1 (2016): 1-2. Web. 12 Aug. 2022.